Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumeblue for detection of non-polypoid colorectal lesions during colonoscopy (China Phase III)
CTR20213000Phase 3Completed
- Sponsor
- Cosmo Pharmaceuticals
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in colorectal neoplasm comparing Lumeblue with Placebo (2 arms). Primary endpoint: Detection rate of non-polypoid colorectal lesions. Started Dec 2021; status: completed.
02
Drugs
lumeblue
03
Conditions
colorectal neoplasm
Beyond the preview
Go deeper on CTR20213000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213000.